FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

APPELROUTH STEWART
2. Issuer Name and Ticker or Trading Symbol

AIM ImmunoTech Inc. [ AIM ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

2117 SW HIGHWAY 484
3. Date of Earliest Transaction (MM/DD/YYYY)

3/8/2023
(Street)

OCALA,, FL 34473
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 3/10/2023  J(5)  68208 D$1.23 (6)148855 D  

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options (1)$29.48 (2)3/8/2023 (3) J (4)  143    3/8/2023 4/30/2027 CommonStock 143 $0 143 D  
Options (1)$28.16 (2)3/8/2023 (3) J (4)  150    3/8/2023 5/15/2027 CommonStock 150 $0 150 D  
Options (1)$25.96 (2)3/8/2023 (3) J (4)  163    3/8/2023 5/31/2027 CommonStock 163 $0 163 D  
Options (1)$21.56 (2)3/8/2023 (3) J (4)  196    3/8/2023 6/15/2027 CommonStock 196 $0 196 D  
Options (1)$21.56 (2)3/8/2023 (3) J (4)  196    3/8/2023 6/30/2027 CommonStock 196 $0 196 D  
Options (1)$21.12 (2)3/8/2023 (3) J (4)  250    3/8/2023 7/15/2027 CommonStock 250 $0 250 D  
Options (1)$18.48 (2)3/8/2023 (3) J (4)  287    3/8/2023 7/31/2027 CommonStock 287 $0 287 D  
Options (1)$18.04 (2)3/8/2023 (3) J (4)  295    3/8/2023 8/15/2027 CommonStock 295 $0 295 D  
Options (1)$15.84 (2)3/8/2023 (3) J (4)  338    3/8/2023 8/31/2027 CommonStock 338 $0 338 D  
Options (1)$16.28 (2)3/8/2023 (3) J (4)  2568    3/8/2023 2/13/2028 CommonStock 2568 $0 2568 D  
Options (1)$16.72 (2)3/8/2023 (3) J (4)  1136    3/8/2023 4/12/2028 CommonStock 1136 $0 1136 D  
Options (1)$13.20 (2)3/8/2023 (3) J (4)  1136    3/8/2023 5/16/2028 CommonStock 1136 $0 1136 D  
Options (1)$13.20 (2)3/8/2023 (3) J (4)  1728    3/8/2023 5/16/2028 CommonStock 1728 $0 1728 D  
Options (1)$13.64 (2)3/8/2023 (3) J (4)  1115    3/8/2023 7/18/2028 CommonStock 1115 $0 1115 D  
Options (1)$9.68 (2)3/8/2023 (3) J (4)  1963    3/8/2023 10/17/2028 CommonStock 1963 $0 1963 D  
Options (1)$9.68 (2)3/8/2023 (3) J (4)  11    3/8/2023 11/14/2028 CommonStock 11 $0 11 D  
Options (1)$9.68 (2)3/8/2023 (3) J (4)  2356    3/8/2023 1/28/2029 CommonStock 2356 $0 2356 D  
Options (1)$9.68 (2)3/8/2023 (3) J (4)  568    3/8/2023 1/28/2029 CommonStock 568 $0 568 D  
Options (1)$2.77 3/8/2023 (3) J (4)  25000    3/8/2023 8/12/2030 CommonStock 25000 $0 25000 D  
Options (1)$1.71 3/8/2023 (3) J (4)  25000    3/8/2023 11/11/2031 CommonStock 25000 $0 25000 D  
Options (1)$0.70 3/8/2023 (3) J (4)  25000    3/8/2023 3/3/2032 CommonStock 25000 $0 25000 D  

Explanation of Responses:
(1) Replacement for previously issued options.
(2) Conversion price reflects reverse split that occurred after original issuance but prior to the date hereof.
(3) Date of re-issuance.
(4) Reporting person transferred options to former spouse in a matrimonial matter.
(5) Reporting person transferred common stock to former spouse in a matrimonial matter.
(6) Cost basis of the weighted average share price.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
APPELROUTH STEWART
2117 SW HIGHWAY 484
OCALA,, FL 34473
X



Signatures
/s/ Stewart L. Appelrouth3/10/2023
**Signature of Reporting PersonDate


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
AIM ImmunoTech (AMEX:AIM)
Graphique Historique de l'Action
De Fév 2024 à Mar 2024 Plus de graphiques de la Bourse AIM ImmunoTech
AIM ImmunoTech (AMEX:AIM)
Graphique Historique de l'Action
De Mar 2023 à Mar 2024 Plus de graphiques de la Bourse AIM ImmunoTech